LTI
XBI icon

Laffer Tengler Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Laffer Tengler Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-90
Closed -$7.47K – 456
2022
Q4 		$7.47K Buy
+90
New +$7.29K ﹤0.01% 381

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Laffer Tengler Investments's XBI Position: Q1 2023 in Review

Laffer Tengler Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 90 shares — an estimated $7.47K sold.

Laffer Tengler Investments first reported a position in XBI in Q4 2022 and held it in 1 quarter. The position peaked at $7.47K in Q4 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

  • Laffer Tengler Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Laffer Tengler Investments sold 90 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $7.47K.
  • Laffer Tengler Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 1 quarter.
  • Laffer Tengler Investments's State Street SPDR S&P Biotech ETF position peaked at $7.47K in Q4 2022.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Laffer Tengler Investments's 13F filing for Q1 2023, filed 9 May 2023.